Novanta Inc. (NOVT)
NASDAQ: NOVT · Real-Time Price · USD
128.87
+1.42 (1.11%)
Jun 27, 2025, 12:06 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Automation Enabling Technologies
496.40M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Growth
1.59%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Post-Q3 2024 Reporting)
455.30M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Post-Q3 2024 Reporting) Growth
12.46%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Revenue (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation
303.68M
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Growth
14.71%
Log In
Log In
Log In
Log In
Upgrade
Other Revenue seg1
648.02M
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Corporate and Shared Services Operating Income
-52.11M
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Operating Income Growth
1.83%
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg2
11.18M
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg2 Growth
-
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Operating Income
113.96M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Operating Income Growth
17.92%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Post-Q3 2024 Reporting)
55.54M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Post-Q3 2024 Reporting) Growth
-13.64%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Operating Income (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg1
180.68M
Log In
Log In
Log In
Log In
Upgrade
Other EBIT seg1 Growth
-
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Corporate and Shared Services Gross Profit
-3.07M
Log In
Log In
Log In
Log In
Upgrade
Corporate and Shared Services Gross Profit Growth
-24.08%
Log In
Log In
Log In
Log In
Upgrade
Other Gross Profit seg2
2.78M
Log In
Log In
Log In
Log In
Upgrade
Other Gross Profit seg2 Growth
-
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Gross Profit
238.86M
Log In
Log In
Log In
Log In
Upgrade
Automation Enabling Technologies Gross Profit Growth
7.00%
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Post-Q3 2024 Reporting)
189.70M
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Post-Q3 2024 Reporting) Growth
-0.56%
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Gross Profit
-
Log In
Log In
Log In
Log In
Upgrade
Precision Medicine and Manufacturing Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Gross Profit
-
Log In
Log In
Log In
Log In
Upgrade
Robotics and Automation Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Gross Profit seg1
431.33M
Log In
Log In
Log In
Log In
Upgrade
Other Gross Profit seg1 Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
United States
493.68M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
14.41%
Log In
Log In
Log In
Log In
Upgrade
Germany
118.54M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-6.33%
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe
129.68M
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Growth
-6.46%
Log In
Log In
Log In
Log In
Upgrade
China
88.93M
Log In
Log In
Log In
Log In
Upgrade
China Growth
22.29%
Log In
Log In
Log In
Log In
Upgrade
Rest of Asia-Pacific
103.18M
Log In
Log In
Log In
Log In
Upgrade
Rest of Asia-Pacific Growth
-1.26%
Log In
Log In
Log In
Log In
Upgrade
Other Geographic
17.69M
Log In
Log In
Log In
Log In
Upgrade
Other Geographic Growth
-9.52%
Log In
Log In
Log In
Log In
Upgrade